Dual-binding Nanoparticles Improve the Killing Effect of T Cells on Solid Tumor.
Luo Zhenyu,Luo Lihua,Lu Yichao,Zhu Chunqi,Qin Bing,Jiang Mengshi,Li Xiang,Shi Yingying,Zhang Junlei,Liu Yu,Shan Xinyu,Yin Hang,Guan Guannan,Du Yongzhong,Cheng Ningtao,You Jian
DOI: https://doi.org/10.1186/s12951-022-01480-z
IF: 10.2
2022-01-01
Journal of Nanobiotechnology
Abstract:Adoptive cell therapy (ACT) was one of the most promising anti-tumor modalities that has been confirmed to be especially effective in treating hematological malignancies. However, the clinical efficacy of ACT on solid tumor was greatly hindered by the insufficient tumor-infiltration of cytotoxic CD8 + T cells. Herein, we constructed a nanoplatform termed dual-binding magnetic nanoparticles (DBMN) that comprised PEG-maleimide (Mal), hyaluronic acid (HA) and Fe3O4 for adoptive T cell-modification and ACT-sensitization. After a simple co-incubation, DBMN was anchored onto the cell membrane (Primary linking) via Michael addition reaction between the Mal and the sulfhydryl groups on the surface of T cells, generating magnetized T cells (DBMN-T). Directed by external magnetic field and in-structure Fe3O4, DBMN-T was recruited to solid tumor where HA bond with the highly expressed CD44 on tumor cells (Secondary Linking), facilitating the recognition and effector-killing of tumor cells. Bridging adoptive T cells with host tumor cells, our DBMN effectively boosted the anti-solid tumor efficacy of ACT in a mouse model and simultaneously reduced toxic side effects.